Allied Healthcare Product Inc. (AHPIQ)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ORTHOPEDIC, PROSTHETIC & SURGICAL APPLIANCES & SUPPLIES
CEO:
Joseph F. Ondrus
Employees:
150
1720 SUBLETTE AVE, ST LOUIS, MO 63110
3147712400

Allied Healthcare Products, Inc. manufactures and markets respiratory products for use in the health care industry. The company offers respiratory care/anesthesia products, including air compressors, calibration equipment, humidifiers, croup tents, and equipment dryers. It also provides medical gas equipment, which include construction products consisting of in-wall medical system components, central station pumps and compressors.

Data derived from most recent annual or quarterly report
Market Cap 2.207 Million Shares Outstanding4.014 Million Avg 30-day Volume 165.091 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-1.34
Price to Revenue0.2419 Debt to Equity0.4712 EBITDA-4.119 Million
Price to Book Value1.2499 Operating Margin-16.933699999999998 Enterprise Value4.191 Million
Current Ratio2.688 EPS Growth-4.19 Quick Ratio0.951
1 Yr BETA 0.891 52-week High/Low 3.67 / 0.5 Profit Margin-19.8229
Operating Cash Flow Growth-8.2507 Altman Z-Score1.4962 Free Cash Flow to Firm 5.842 Million
View SEC Filings from AHPIQ instead.

View recent insider trading info

Allied Healthcare Product Inc. YCharts
Yahoo! Finance finviz
SEC Web Site SEC DEF 14A Filings

Funds Holding AHPIQ (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
Click for Additional Filters
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding AHPIQ

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Financial Reporting

Ownership

  • 4: filed on 2021-11-30 by WEIL JOHN D
  • 4: filed on 2021-11-15 by ROOT JOSEPH ERNEST JR
  • 4: filed on 2021-11-15 by GRAVES JUDY T
  • 4: filed on 2021-11-15 by DEUSER SUSAN M
  • 4: filed on 2021-11-15 by WEIL JOHN D
  • 3: filed on 2021-07-08 by KROUPA KEVIN D
  • 4: filed on 2021-03-10 by REFSLAND EARL R
  • 4: filed on 2021-03-05 by REFSLAND EARL R
  • 4: filed on 2021-03-04 by REFSLAND EARL R
  • 4: filed on 2021-03-03 by REFSLAND EARL R

    • Events (8k)

  • 8-K: filed on 2023-05-15:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2023-05-12:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 1.03: Bankruptcy or Receivership
    Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-03-16:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 2.06: Material Impairments
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-27:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-02-14:
    Item 2.02: Results of Operations and Financial Condition
  • 8-K: filed on 2023-02-08:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
  • 8-K: filed on 2023-01-31:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-26:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 2.06: Material Impairments
    Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2023-01-11:
    Item 8.01: Other Events
  • 8-K: filed on 2022-12-22:
    Item 2.05: Cost Associated with Exit or Disposal Activities
    Item 2.06: Material Impairments

    • Proposed Sales (Form 144)

    Proxy

    Prospectus

    All

    Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    none

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    WEIL JOHN D

    • Director
    		 172,001 2021-11-26 0

    GRAVES JUDY T

    • Director
    		 1,750 2021-11-11 0

    ROOT JOSEPH ERNEST JR

    • Director
    		 500 2021-11-11 0

    DEUSER SUSAN M

    • Director
    		 6,500 2021-11-11 0

    KROUPA KEVIN D VICE PRESIDENT OF OPERATIONS

    • Officer
    		 0 2021-07-06 0

    REFSLAND EARL R PRESIDENT AND CEO

    • Officer
    • Director
    		 0 2021-03-09 0

    ONDRUS JOSEPH F VICE PRESIDENT OF OPERATIONS

    • Officer
    		 0 2020-10-21 0

    PECK WILLIAM A

    • Director
    		 0 2018-11-08 0

    RILEY ANDREW VP OF OPERATIONS

    • Officer
    		 0 2014-07-28 0

    DUNN DANIEL C VP - FINANCE AND CFO

    • Officer
    		 1,306 2011-08-25 0

    ROSENTRATER ELDON P VP - ADMINISTRATION

    • Officer
    		 13,169 2011-08-25 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed    		 Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
    No current insider transactions

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 22:15:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 21:45:05 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 21:15:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 20:45:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 20:15:05 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 19:45:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 19:15:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 18:45:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 18:15:03 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 17:45:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 17:15:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 16:45:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 16:15:03 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 15:45:03 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 15:15:03 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 14:45:05 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 14:15:04 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 13:45:05 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 13:15:03 UTC -23.7867 28.8567 90000
    ALLIED HEALTHCARE PRODUCTS AHPIQ 2023-05-29 12:45:03 UTC -23.7867 28.8567 90000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments